Awareness on Management of Adenocarcinoma of the Palate | 61356

Journal of Research in Medical and Dental Science
eISSN No. 2347-2367 pISSN No. 2347-2545

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Awareness on Management of Adenocarcinoma of the Palate

Author(s): Vishnu Prasanna SG and Dhanraj Ganapathy*


Minor salivary gland neoplasms constitute approximately 25% of all the salivary gland tumours. The incidence of these tumors turning into malignancy is slightly greater than half but varies by series. Adenocarcinoma is an uncommon tumour that usually affects the minor salivary glands, particularly in the palate. Adenocarcinomas are distinctive neoplasms which may be sub classified according to their tissue growth patterns or histo-cytomorphology. Polymorphous low-grade adenocarcinoma (PLGA) is a minor salivary gland carcinoma usually arises intraorally, which occurs primarily in the palate. A survey was conducted in January 2020 among dental students. It was an online questionnaire based study, conducted to assess the awareness on the management of adenocarcinoma. 150 dental students (Third years, Final years, Interns) participated in this study. The data collected was entered in an Excel sheet and subjected to statistical analysis using SPSS version 20. Chi square test was done. 25.33% of third years, 29.33% of final years and 32% of interns were aware of the term adenocarcinoma. 32% of third years, 30.67% of final years, 33.33% of interns have come across patients with adenocarcinoma. 16.67% of third years, 25.33% of final years and 30% of interns knew how adenocarcinoma was caused. 14% of third years, 27.33% of final years, 26.67% of interns were aware of diagnostic aids. 16% of third years, 8.67% of final years, 30% of interns have seen a patient with similar lesions. Chi square test shows p<0.000, significant. It was seen that Interns had a good awareness of management of adenocarcinoma when compared to the final and third years.

Share this article